This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical tri…

Stargardt DiseaseCone Rod DystrophyJuvenile Macular Degeneration+1 more

~Estimated

~$10 – $8,750

Ascidian Therapeutics, IncNCT06467344

Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligib…

Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more

~Estimated

~$10 – $1,050

Ascidian Therapeutics, IncNCT06445322